They included 65 patients with generalized lipodystrophy, 87 with partial lipodystrophy and 42 with defective insulin signaling, of whom 16 had a genetic INSR pathogenic variant, 25 had type B IR and 1 had a TBC1D4 defect. This evidence concerns the gene INSR and partial lipodystrophy.